Medicines Patent Pool Aims To Increase Access To HIV Drugs In Developing Countries 10/03/2011 by Tavengwa Runyowa for Intellectual Property Watch 5 Comments The newly created Medicines Patent Pool promises to increase access to HIV/AIDS medications in developing markets. Based in Geneva, Switzerland, the pool operates a scheme in which pharmaceutical patent holders voluntarily licence their drugs to generic manufacturers who then produce more affordable versions for patients in poorer countries
Canada Considers Amendment To Compulsory Licensing Regime For Medicines Access 08/03/2011 by Tavengwa Runyowa for Intellectual Property Watch Leave a Comment The Canadian Parliament is on the verge of amending the nation’s patent regime to make it easier for generic drug companies to provide low-cost HIV medications for developing countries.
Would Canada-EU Trade Proposals Add $2.8 Billion Price Tag To Drugs Bill? 08/02/2011 by Intellectual Property Watch 1 Comment A study by the Canadian Generic Pharmaceuticals Association (CGPA) suggests that the European Union’s (EU) proposed changes to Canada’s patent system could add nearly $3 billion to Canada’s prescription drug bill.
WIPO Survey On Patent Filing Strategies Shows Rise In Optimism 07/02/2011 by Tavengwa Runyowa for Intellectual Property Watch Leave a Comment A recent economic survey by the World Intellectual Property Organization (WIPO) assessed the expected growth in domestic and international patent filings in 2010 compared to 2009. The highest expected growth rates were reported in Asian countries, with modest and declining growth reported in Europe and the United States respectively.